600285 Henan Lingrui Pharmaceutical
- 22.17
- -0.70-3.06%
About Henan Lingrui Pharmaceutical Company
The company is a national high-tech enterprise and an A-share listed company whose main business is the production and operation of pharmaceuticals and medical devices. The company has more than 100 kinds of orthopedic, cardiology, encephalology, and anesthesiology products, including Tongluo Pain Relief Cream, Bone Strengthening Musk Pain Relief Cream, Peiyuan Tongnao Capsules, Danlu Tongdu Tablets, Stomach Pain Relief Tablets, Shenqi Sugar Reduction Capsules, Fentanyl Transdermal Patches, etc., as well as national traditional Chinese medicine protected varieties and national medical insurance products and base drug products. Currently, many companies are holding and participating in shares, and have multiple scientific research and production bases. Among them, Ling Rui Pharmaceutical's 10 billion paste production base is leading the domestic market, and Lingrui Xinyang Health Industrial Park is an advanced large-scale oral medicine production base in China. The company's industry is pharmaceutical manufacturing. Its main business involves R&D, production and sales of pharmaceuticals. The main product line focuses on areas with traditional Chinese medicine treatment advantages such as orthopedic diseases and cardiovascular diseases. The company's main products include orthopedic pain relief cream, blood revitalizing and pain relieving tincture, bone strengthening musk pain cream, wet pain relief cream, joint pain relief cream, indomethacin patches, Danlu Tongdu tablets, etc.; the main products for treating chronic diseases such as cardiovascular and cerebrovascular diseases include Peiyuan Tongnao capsules, Shenqi hypoglycemic capsules, Danyu Tongmai granules, etc.; The main products for treating pediatric diseases include abdominal relief paste, pediatric aminophen, hypothermia tablets, etc.; the main treatment products include respiratory diseases Bluestone granules, Quning capsules, etc.; anesthetic products are retinoic fentanyl transdermal patches. Corporate honors: 2011 Governor's Quality Award, National Certified Enterprise Technology Center, Henan Provincial Contract-abiding and Credit-worthy Enterprise, National Pharmaceutical Industry Advanced Team, National Top 50 Traditional Chinese Medicine Industry Enterprises, National Advanced Chinese Medicine System Collective, National Technological Innovation Demonstration Enterprise, etc.
Company Profile
Company Executives
- Name
- Position
- Salary
- wei xiong
- Chairman, Directors, General Manager, Chairman of the Strategy Committee, Nomination Committee Members, Member of the Remuneration and Assessment Committee
- 1.80M
- guoxin feng
- Directors, Board Secretary
- 953.90K
- xizhen wu
- Directors, Deputy General Manager, Nomination Committee Members
- --
- zirun pan
- Directors, Audit Committee Member
- 947.70K
- zhijun zhao
- Directors, Audit Committee Members, Strategy Committee Member
- 707.10K
- yan chen
- Directors, Deputy General Manager, Member of the Remuneration and Assessment Committee
- 972.30K
- qinyu zhang
- Independent Directors, Nomination Committee Members, Strategy Committee Members, Chairman of the Remuneration and Assessment Committee, Audit Committee Members
- --
- hui li
- Independent Directors, Strategy Committee Member, Chairman of the Nomination Committee, Member of the Remuneration and Assessment Committee, Audit Committee Member
- 41.70K
- jun yang
- Independent Directors, Chairman of the Audit Committee, Strategy Committee Member, Nomination Committee Members
- 58.30K
- gaili mao
- Securities Affairs Representative
- --
- jin li
- Chairman of the Supervisory Board, Auditors
- --
- jiashu jiang
- Auditors
- 618.20K
- qiang ye
- Deputy General Manager
- 938.10K
- lei li
- Deputy General Manager
- 783.70K
- huibin wu
- Deputy General Manager
- 1.16M
- peng yu
- Chief Financial Officer
- 950.80K
- baodong cheng
- Employee Supervisors
- 726.90K
No Data
